159 related articles for article (PubMed ID: 6604064)
1. Sézary cells with an unusual phenotype, their modulation with 12-O-tetradecanoyl phorbol-13-acetate (TPA) in vitro, and their relationship to T-cell development.
Kvaløy S; Lindmo T; Davies C; Wisløff F; Godal T
J Clin Immunol; 1983 Jul; 3(3):212-21. PubMed ID: 6604064
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic modulation of chronic lymphocytic leukemia cells by phorbol ester: induction of IgM secretion and changes in the expression of B cell-associated surface antigens.
Gordon J; Mellstedt H; Aman P; Biberfeld P; Klein G
J Immunol; 1984 Jan; 132(1):541-7. PubMed ID: 6606672
[TBL] [Abstract][Full Text] [Related]
3. TPA (12-O-tetradecanoyl-phorbol-13-acetate) activation and differentiation of human peripheral B lymphocytes.
Aman P; Gordon J; Klein G
Immunology; 1984 Jan; 51(1):27-34. PubMed ID: 6606617
[TBL] [Abstract][Full Text] [Related]
4. Distinctive phorbol ester-induced morphological and surface antigen changes in mycosis fungoides, the Sézary syndrome, and adult T-cell leukemia.
Kadin ME; Nasu K; Sako D; Su IJ
Cancer Res; 1984 Aug; 44(8):3383-7. PubMed ID: 6611200
[TBL] [Abstract][Full Text] [Related]
5. Identification by monoclonal antibodies of T-cell subpopulations activated by 12-O-tetradecanoylphorbol-13-acetate (TPA).
Kaplan JH; Lee LS; Lockwood SH
Immunol Lett; 1982 May; 4(5):269-73. PubMed ID: 6980189
[TBL] [Abstract][Full Text] [Related]
6. Proliferative response of normal and activated human lymphocytes to tetradecanoyl phorbol acetate.
Ashman LK
Cell Immunol; 1984 Sep; 87(2):613-25. PubMed ID: 6331899
[TBL] [Abstract][Full Text] [Related]
7. Differentiation of human T-lymphoid leukemia cells into cells that have a suppressor phenotype is induced by phorbol 12-myristate 13-acetate.
Ryffel B; Henning CB; Huberman E
Proc Natl Acad Sci U S A; 1982 Dec; 79(23):7336-40. PubMed ID: 6218499
[TBL] [Abstract][Full Text] [Related]
8. TPA, tumor promoter-induced suppression of immunoglobulin secretion in human blood lymphocytes.
Jagielski P; Gregg SL; Gajl-Peczalska KJ
J Immunol; 1983 Mar; 130(3):1159-63. PubMed ID: 6600475
[TBL] [Abstract][Full Text] [Related]
9. Secretory leukemic B cells express T cell markers in vitro. A phenomenon suppressed by TPA.
Efremidis AP; Haubenstock HS; Papadopoulos NM; Holland JF; Bekesi JG
J Immunopharmacol; 1986; 8(2):129-44. PubMed ID: 3487592
[TBL] [Abstract][Full Text] [Related]
10. Changes in SRBC binding capacity and T-surface antigen expression on human peripheral blood lymphocytes stimulated by 12-O-tetradecanoylphorbol-13-acetate (TPA).
Matera L; Foa R; Marmont F; Massaia M; Palumbo A; Pegoraro L
J Clin Lab Immunol; 1983 Sep; 12(1):57-61. PubMed ID: 6688831
[TBL] [Abstract][Full Text] [Related]
11. Phorbol ester-induced differentiation of chronic B lymphocytic leukaemia cells--regulatory impact of autologous and allogeneic accessory cells.
Danersund A; Tötterman TH; Nilsson K; Egle-Jansson I; Kabelitz D; Sjöberg O
Clin Exp Immunol; 1985 Mar; 59(3):644-52. PubMed ID: 3872753
[TBL] [Abstract][Full Text] [Related]
12. Suppressive activity of 12-O-tetradecanoyl phorbol-13-acetate on the induction of cytotoxic T cells in vitro.
Yamashita U
Jpn J Cancer Res; 1985 Jul; 76(7):618-25. PubMed ID: 3928558
[TBL] [Abstract][Full Text] [Related]
13. Phorbol ester-induced differentiation of a non-T, non-B leukemic cell line: model for human lymphoid progenitor cell development.
LeBien TW; Bollum FJ; Yasmineh WG; Kersey JH
J Immunol; 1982 Mar; 128(3):1316-20. PubMed ID: 7035564
[TBL] [Abstract][Full Text] [Related]
14. In vitro maturation of B cells in chronic lymphocytic leukemia. I. Synergistic action of phorbol ester and interleukin 2 in the induction of Tac antigen expression and interleukin 2 responsiveness in leukemic B cells.
Kabelitz D; Pfeffer K; von Steldern D; Bartmann P; Brudler O; Nerl C; Wagner H
J Immunol; 1985 Oct; 135(4):2876-81. PubMed ID: 2993419
[TBL] [Abstract][Full Text] [Related]
15. Acquisition of deoxyguanosine resistance by TPA-induced T lymphoid lines.
Sacchi N; Fiorini G; Plevani P; Badaracco G; Breviario D; Ginelli E
J Immunol; 1983 Apr; 130(4):1622-6. PubMed ID: 6601131
[TBL] [Abstract][Full Text] [Related]
16. Alterations in cell surface phenotype of T- and B-cell chronic lymphocytic leukemia cells following in vitro differentiation by phorbol ester.
Shawler DL; Glassy MC; Wormsley SB; Royston I
J Natl Cancer Inst; 1984 May; 72(5):1059-63. PubMed ID: 6609264
[TBL] [Abstract][Full Text] [Related]
17. Alteration in glycosphingolipid pattern during phorbol-12-myristate-13-acetate-induced cell differentiation in human T-lymphoid leukemia cells.
Kiguchi K; Henning-Chubb C; Huberman E
Cancer Res; 1986 Jun; 46(6):3027-33. PubMed ID: 3486042
[TBL] [Abstract][Full Text] [Related]
18. The effect of 12-O-tetradecanoyl-phorbol 13-acetate on the ribonuclease activity of circulating human lymphocytes.
Kyner D; Christman JK; Acs G
Eur J Biochem; 1979 Sep; 99(2):395-9. PubMed ID: 315310
[TBL] [Abstract][Full Text] [Related]
19. An OKT4+ T-cell population with suppressor activity in Sézary syndrome.
Farnarier-Seidel C; Kaplanski S; Golstein MM; Jancovici E; Sayag J; Depieds R
Scand J Immunol; 1983 Nov; 18(5):389-98. PubMed ID: 6227982
[TBL] [Abstract][Full Text] [Related]
20. Modulation of cell surface antigens induced by 12-O-tetradecanoyl-phorbol 13-acetate in two myeloblastic cell lines, a promyelocytic cell line, and a monoblastic cell line: detection with five monoclonal antibodies.
Sugimoto T; Tatsumi E; Takeda K; Minato K; Sagawa K; Minowada J
J Natl Cancer Inst; 1984 Apr; 72(4):923-8. PubMed ID: 6368942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
